A decade of dividends, a stock that stood still
clorox (NYSE:CLX | clx price prediction) Spent the last 10 years doing what a consumer should do: getting paid reliably, growing dividends annually, and working through cycles. The pandemic briefly turned cleaning brands into pantry essentials, sending shares above prior highs. Then came margin compression, the 2023 cyber attack and an ambitious $580 million ERP overhaul, which the company completed in the winter of fiscal 2026.
CEO Linda Rendle closed the acquisition of GOJO Industries (Purell) on April 1, 2026, expanding the hygiene portfolio with Glad, Brita, Kingsford, Hidden Valley and Burt’s Bees. Its quarterly dividend of $1.24 per share was paid on May 8, 2026, increased from $1.22 a year earlier.
Your $1,000 is mostly just sitting there
Here’s how an investment in Clorox stock might have performed using dividend-adjusted prices through May 7, 2026, and compared to S&P 500 returns:
- 1-Year Returns: $1,000 became $706 (−29.4%). S&P 500: $1,304 (+30.4%).
- 5 Year Returns: $1,000 became $597 (−40.3%). S&P 500: $1,733 (+73.3%).
- 10 Year Returns: $1,000 became $940 (−6.0%). S&P 500: $3,553 (+255.3%).
Dividends took a huge hit. Quarterly payouts have increased from $0.77 in 2016 to $1.24 today, putting total returns well above the value-only path. Still, a decade of compounding dividends barely kept the situation afloat, while the S&P 500 more than tripled. Timing especially punished latecomers: The 2020 surge to $239 looked like a runway and turned into a ceiling.
The bull case hinges on dividend holding
The bullish case for Clorox here depends on whether the adjusted EPS guidance of $5.45 to $5.65 pans out and the 5.76% dividend yield is sustained. On the bullish side: ERP disruption reduces, Pure adds scale, gross margins normalize, and forward P/E gets higher near 13. Director Pierre Breber purchased 5,000 shares on May 5 at approximately $85.82, the kind of gesture one might respect. Additionally, Clorox is currently on track to become dividend king In 2027.
If guidance cuts continue, the bearish case becomes stronger. Adjusted EPS guidance has already been cut to $5.45-$5.65 from $5.95-$6.30, organic sales are down about 9%, and the company has priced $1.5 billion in senior notes, while several law firms are circling. If EPS falls further, the payout ratio moves uncomfortably close to 100%.
The takeaway: The brand and dividend record are too durable to dismiss at $92, but beating the S&P 500 from here will depend on management execution rather than market beta.